We are live on ! Find out more
FLC

Fifth Lane Capital Portfolio holdings

AUM $1.63M
1-Year Est. Return 7.5%
This Fund
S&P 500
This Quarter Est. Return
+11.54%
1 Year Est. Return
+7.5%
3 Year Est. Return
+79.98%
5 Year Est. Return
10 Year Est. Return
AUM
$177M
AUM Growth
+$66.1M
Cap. Flow
+$68.9M
Cap. Flow %
38.92%
Top 10 Hldgs %
50.27%
Holding
262
New
77
Increased
16
Reduced
22
Closed
67
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENZ
76
DELISTED
Enzo Biochem, Inc.
ENZ
$133K 0.08%
+54,861
New +$81.6K
ARNC
77
CALL
DELISTED
Arconic Corporation
ARNC
$131K 0.07%
+5,000
New +$123K
JNCE
78
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$92.5K 0.05%
+50,000
New +$61.9K
DHAI
79
DELISTED
DIH Holdings US
DHAI
$86.4K 0.05%
+27,477
New +$7.07M
PDLB icon
80
Ponce Financial Group
PDLB
$485M
$78.5K 0.04%
+10,000
New +$90.6K
ACAXR
81
DELISTED
Alset Capital Acquisition Corp Right
ACAXR
$65.2K 0.04%
283,444
SCRMW
82
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$59.1K 0.03%
251,340
-50,000
-17% -$12.3K
CANO
83
DELISTED
Cano Health, Inc.
CANO
$52.1K 0.03%
572
-111
-16% -$15.1K
CNSL
84
CALL
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$51.6K 0.03%
+20,000
New +$71.7K
WTMAR
85
DELISTED
Welsbach Technology Metals Acquisition Corp. one right to receive 1/10th of a share of common stock
WTMAR
$50.3K 0.03%
251,397
BRACR
86
DELISTED
Broad Capital Acquisition Corp Rights
BRACR
$46.5K 0.03%
310,000
CCV.WS
87
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
$30.8K 0.02%
164,732
-15,419
-9% -$2.64K
AIBBR
88
DELISTED
AIB Acquisition Corp Right
AIBBR
$30K 0.02%
200,240
KACLR
89
DELISTED
Kairous Acquisition Corp. Limited Rights
KACLR
$25.9K 0.01%
171,999
-501
-0.3% -$109
MSSAR
90
DELISTED
Metal Sky Star Acquisition Corporation Right
MSSAR
$25K 0.01%
157,755
+53,048
+51% +$7.67K
DHAIW
91
DELISTED
DIH Holding US Inc Warrants
DHAIW
$23.8K 0.01%
1,002,616
+200,000
+25% +$4.12K
CVIIW
92
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$20.8K 0.01%
169,594
+20,781
+14% +$1.77K
FORG
93
CALL
DELISTED
ForgeRock, Inc.
FORG
$20.6K 0.01%
+1,000
New +$20.3K
ROCAR
94
DELISTED
ROC Energy Acquisition Corp. Rights
ROCAR
$20.3K 0.01%
60,000
PPHPR
95
DELISTED
PHP Ventures Acquisition Corp. Rights
PPHPR
$20.3K 0.01%
100,000
BWAQR
96
DELISTED
Blue World Acquisition Corporation Right
BWAQR
$20.1K 0.01%
200,000
-300,100
-60% -$28.3K
VIEW
97
DELISTED
View, Inc. Class A Common Stock
VIEW
$20K 0.01%
667
+493
+283% +$20.4K
CCVI.WS
98
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$19.4K 0.01%
176,749
+6,000
+4% +$541
BZAIW
99
Blaize Holdings Warrants
BZAIW
$6.52M
$15.9K 0.01%
348,666
-44,989
-11% -$1.27K
FEXDR
100
DELISTED
Fintech Ecosystem Development Corp. Right
FEXDR
$15.6K 0.01%
134,730

Similar funds

Fifth Lane Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Fifth Lane Capital held 262 positions worth $177M, up 60% from $111M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Fifth Lane Capital deployed $68.9M of net new capital in Q1 2023, opening 77 new positions and adding to 16 existing holdings. Its largest new stake was L Catterton Asia Acquisition Corp Class A Ordinary Shares: 900,000 shares worth $9.2M.

By sector, the portfolio is most concentrated in Healthcare at 9.8% of assets, up from 7.4% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Activision Blizzard, an estimated $4.61M trimmed.

  • Fifth Lane Capital's largest Q1 2023 buy was L Catterton Asia Acquisition Corp Class A Ordinary Shares: 900,000 shares worth $9.2M.
  • Fifth Lane Capital added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $9.95M increase.
  • Fifth Lane Capital's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $4.61M.
  • Fifth Lane Capital fully exited Meridian Bioscience Inc in Q1 2023, selling an estimated $6.17M.
  • Fifth Lane Capital's ten largest holdings make up 50% of its $177M portfolio in Q1 2023.
  • Fifth Lane Capital opened 77 new positions and closed 67 in Q1 2023.
  • Fifth Lane Capital's portfolio value rose 60% quarter-over-quarter to $177M.

Based on Fifth Lane Capital's 13F filing for Q1 2023, filed 15 May 2023.